Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis

J. Lovell, Daniel; H. Giannini, Edward; Reiff, Andreas; Dunkel Cawkwell, Gail; D. Silverman, Earl; J. Nocton, James; D. Stein, Leonard; Gedalia, Abraham; T. Ilowite, Norman; A. Wallace, Carol; B. Whitmore, James; K. Finck, Barbara

doi:10.1056/nejm200003163421103

Public

Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis

Published in New England Journal of Medicine • Mar 16, 2000

Authors:

Daniel J. Lovell

Edward H. Giannini

Andreas Reiff

Abstract

BACKGROUND: We evaluated the safety and efficacy of etanercept, a soluble tumor necrosis factor receptor (p75):Fc fusion protein, in children with polyarticular juvenile rheumatoid arthritis who did not tolerate or had an inadequate response to methotrexate. METHODS: Patients 4 to 17 years old recei...

Subject

Etanercept

Medicine

Placebo

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!